Position in LLY
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$7,127,297
-$1,191,801 QoQ
Shares Held
7,749
+0.1% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.83%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 5%
Shared 0%
None 95%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Parkside Financial Bank & Trust holds $28,780,130 across 15 Drug Manufacturers - General names. LLY ranks #1 (24.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
7,749 | $7,127,297 | |
| 2 | ABBV |
AbbVie Inc.
|
28,631 | $6,226,955 | |
| 3 | JNJ |
Johnson & Johnson
|
20,434 | $4,994,886 | |
| 4 | MRK |
Merck & Co., Inc.
|
25,825 | $3,106,488 | |
| 5 | PFE |
Pfizer Inc
|
72,976 | $2,049,165 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
27,005 | $1,637,853 | |
| 7 | AMGN |
Amgen Inc
|
3,990 | $1,403,881 | |
| 8 | NVS |
Novartis AG
|
5,576 | $851,733 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $7,127,297 | 7,749 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $8,319,098 | 7,741 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $5,927,747 | 7,769 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $6,121,649 | 7,853 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $5,454,308 | 6,604 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $4,977,856 | 6,448 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $5,662,927 | 6,392 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $5,767,270 | 6,370 | Shares | Sole | 2024-08-05 | |
| 2024-03-31 | $4,897,257 | 6,295 | Shares | Sole | 2024-05-01 | |
| 2023-12-31 | $2,855,141 | 4,898 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $1,357,864 | 2,528 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,071,150 | 2,284 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $765,139 | 2,228 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $816,554 | 2,232 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $697,465 | 2,157 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $832,622 | 2,568 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $706,474 | 2,467 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $616,522 | 2,232 | Shares | Defined | 2022-03-01 | |
| 2021-09-30 | $528,180 | 2,286 | Shares | Defined | 2021-10-29 | |
| 2021-06-30 | $515,042 | 2,244 | Shares | Defined | 2021-08-06 | |
| 2021-03-31 | $406,146 | 2,174 | Shares | Defined | 2021-05-10 | |
| 2020-12-31 | $397,617 | 2,355 | Shares | Defined | 2021-02-09 | |
| 2020-09-30 | $314,393 | 2,124 | Shares | Defined | 2020-11-06 | |
| 2020-06-30 | $503,867 | 3,069 | Shares | Defined | 2020-08-10 | |
| 2020-03-31 | $419,627 | 3,025 | Shares | Defined | 2020-05-05 | |
| No filing history on record for this holder in this stock. | ||||||